What is the difference between Semaglutide, Ozempic, Wegovy, and Mounjaro
Johnston MV, Blue ME, Naidu S
Federal court is the appropriate venue when there are parties from two different states
For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM, that explain poor responders to their medications. For now, the mechanism driving GLP-1 resistance remains unresolved, but it is likely complex and multifactorial, Gloyn said
doi: 10.1080/00218839.2020.1722356 88
Taken together, these findings suggest that semaglutide can significantly curb the risk of clinically important kidney outcomes and death from cardiovascular causes in type 2 diabetes patients suffering from chronic kidney disease (CKD), the authors of the NEJM paper wrote